51 – 60 of 288
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Protocolized reduction of non-resuscitation fluids versus usual care in septic shock patients (REDUSE) : a randomized multicentre feasibility trial
- Contribution to journal › Article
-
Mark
Risk of infective endocarditis and complicated infection in Staphylococcus aureus bacteremia – a retrospective cohort study on the role of bacteriuria
- Contribution to journal › Article
-
Mark
Multimodal Mass Spectrometry Identifies a Conserved Protective Epitope in S. pyogenes Streptolysin O
- Contribution to journal › Article
-
Mark
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
- Contribution to journal › Article
-
Mark
Acoustic Enrichment of Heterogeneous Circulating Tumor Cells and Clusters from Metastatic Prostate Cancer Patients
- Contribution to journal › Article
-
Mark
Population scale proteomics enables adaptive digital twin modelling in sepsis
(2024)
- Working paper/Preprint › Preprint in preprint archive
-
Mark
Silica seed particles improve the efficiency and throughput of nanoparticle acoustic trapping
- Contribution to journal › Article
-
Mark
EVALUATION OF A NEUROCOGNITIVE SCREENING FOR OUT-OF-HOSPITAL CARDIAC ARREST SURVIVORS
(2024) ACC.24 – American College of Cardiology Meeting 2024 In Journal of the American College of Cardiology 83(13, Supplement). p.1198-1198
- Contribution to journal › Published meeting abstract
-
Mark
Protective Non-neutralizing anti-N-terminal Domain mAb Maintains Fc-mediated Function against SARS-COV-2 Variants up to BA.2.86-JN.1 with Superfluous In Vivo Protection against JN.1 Due to Attenuated Virulence
- Contribution to journal › Article
-
Mark
Protective non-neutralizing SARS-CoV-2 monoclonal antibodies
- Contribution to journal › Scientific review
